• FirefoxInstall the new Firefox »
  •  Dow down 0.06% Nasdaq up 0.42%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow down 0.06% Nasdaq up 0.42%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolNamePrice52-Wk RangeMkt CapAvg VolEPSP/EYieldPrice/SalesEBITDA
    Merck & Co. Inc. 58.96 52.49 63.62 168.09B 10,706,700 4.07 14.49 3.10 3.95 15.22B
    No such ticker symbol: REAL-TIMETry Symbol Lookup
    {"s" : "mrk","k" : "l84,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Today
    Decision on Ebola mass vaccination in August at earliest - WHO Reuters06:43am EST
    Decision on widespread Ebola vaccination in August at earliest - WHO Reuters05:42am EST
    Thursday February 26, 2015
    3:21 pm Merck's 9-Valent HPV vaccine GARDASIL recommended by CDC's advisory committee on immunization for females aged 9-26 and males aged 9-21 Briefing.com03:21pm EST
    Merck’s 9-Valent HPV Vaccine, GARDASIL®9, Recommended by CDC’s Advisory Committee on Immunization Practices for Females Aged 9-26 and Males Aged 9-21 Business Wire03:18pm EST
    Wednesday February 25, 2015
    Spark Therapeutics stock soars CNBC05:23pm EST
    New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe/simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions Business Wire08:00am EST
    Tuesday February 24, 2015
    Merck Strikes Deal with NGM to Develop Novel Biologics - Analyst Blog Zacks06:05pm EST
    Merck takes equity, links up with diabetes drug developer NGM at American City Business Journals02:15pm EST
    Merck Announces Second-Quarter 2015 Dividend Business Wire12:51pm EST
    [video]Merck & Company Grants Free License for Pediatric HIV Drug at TheStreet10:40am EST
    Merck grants free license for pediatric HIV drug AP06:52am EST
    Merck Announces Collaboration with the Medicines Patent Pool to Expand Access to Pediatric Formulations of Raltegravir in Developing Countries Business Wire03:00am EST
    Monday February 23, 2015
    Agilent-ONO Companion Diagnostics Aim - Analyst Blog Zacks06:26pm EST
    Merck, on Behalf of Its Wholly Owned Subsidiary Cubist Pharmaceuticals, Announces Results of Tender Offer for Cubist’s 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes Due 2018 and 1.875% Convertible Senior Notes Due Business Wire06:22pm EST
    Biotech battles 'Superbug' CNBC05:15pm EST
    Merck to team With NGM to develop diabetes and obesity treatments at MarketWatch11:08am EST
    Merck’s Research Man Saved Biotech Deal With Juicy Pitch at Bloomberg10:47am EST
    Merck to Team With NGM to Develop Diabetes, Obesity Treatments at The Wall Street Journal08:25am EST
    Merck Bets $450M On 'Old School' Biotech From NGM at Forbes07:00am EST
    NGM and Merck Announce Broad Strategic Collaboration to Discover, Develop and Commercialize Novel Biologic Therapeutics Business Wire07:00am EST
    Friday February 20, 2015
    Eli Lilly Extends Phase III Cholesterol Study by Six Months - Analyst Blog Zacks02:40pm EST
    What's in Store for Endocyte (ECYT) this Earnings Season? - Analyst Blog Zacks12:30pm EST